We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





ERBA Mannheim Unveils Next-Generation Automation

By LabMedica International staff writers
Posted on 12 Aug 2019
Print article
Image: The NEXUS next-generation automation solution is designed for advanced automation across immunology, clinical chemistry and hematology (Photo courtesy of ERBA Mannheim).
Image: The NEXUS next-generation automation solution is designed for advanced automation across immunology, clinical chemistry and hematology (Photo courtesy of ERBA Mannheim).
ERBA Mannheim (London, UK) unveiled the Erba NEXUS next-generation automation solution at AACC 2019. Aimed at delivering mid-scale, advanced automation across immunology, clinical chemistry and hematology, the Erba NEXUS range employs advanced technology, including AI-based blood cell image analysis, advanced CLIA magnetic beads, thick film ISE analysis and an intuitive sample transport system, to deliver affordable modular automation.

The hematology system uses a unique combination of ultra-high definition imaging, AI and traditional methods to analyze thousands of blood cells per minute for improved turn-around time. The immunoassay system uses high sensitivity CLIA technology with proprietary magnetic bead design with a menu of over 100 parameters, while the chemistry system uses advanced thick-film ISE analysis technology and innovative reagent management to deliver improved workflow and enhanced analytical result quality.

Additionally, the company also exhibited the XL200 and XL640 – its signature chemistry analyzers which have been upgraded to include a touch screen with improved software for easier operation, longer walk-away time and faster TAT. Also on display at the tradeshow was the ELAN 30s – a new fully automated compact benchtop ELISA microstrip processor with easy to use software, including QC reports and the ability to simultaneously perform six different tests.

Among its existing suite of solutions featured at AACC 2019 was the LAURA XL fully automatic urine analyzer and the H560 and ELITE 580 fully automatic hematology analyzers. The company also showcased its new LIMS software with mobile app for providing high function device interfacing and remote online approval of patient reports, thus eliminating need for expensive LIS systems.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.